Literature DB >> 15778506

Fluid shear stress synergizes with insulin-like growth factor-I (IGF-I) on osteoblast proliferation through integrin-dependent activation of IGF-I mitogenic signaling pathway.

Sonia Kapur1, Subburaman Mohan, David J Baylink, K-H William Lau.   

Abstract

This study tested the hypothesis that shear stress interacts with the insulin-like growth factor-I (IGF-I) pathway to stimulate osteoblast proliferation. Human TE85 osteosarcoma cells were subjected to a steady shear stress of 20 dynes/cm(2) for 30 min followed by 24-h incubation with IGF-I (0-50 ng/ml). IGF-I increased proliferation dose-dependently (1.5-2.5-fold). Shear stress alone increased proliferation by 70%. The combination of shear stress and IGF-I stimulated proliferation (3.5- to 5.5-fold) much greater than the additive effects of each treatment alone, indicating a synergistic interaction. IGF-I dose-dependently increased the phosphorylation level of Erk1/2 by 1.2-5.3-fold and that of IGF-I receptor (IGF-IR) by 2-4-fold. Shear stress alone increased Erk1/2 and IGF-IR phosphorylation by 2-fold each. The combination treatment also resulted in synergistic enhancements in both Erk1/2 and IGF-IR phosphorylation (up to 12- and 8-fold, respectively). Shear stress altered IGF-IR binding only slightly, suggesting that the synergy occurred primarily at the post-ligand binding level. Recent studies have implicated a role for integrin in the regulation of IGF-IR phosphorylation and IGF-I signaling. To test whether the synergy involves integrin-dependent mechanisms, the effect of echistatin (a disintegrin) on proliferation in response to shear stress +/- IGF-I was measured. Echistatin reduced basal proliferation by approximately 60% and the shear stress-induced mitogenic response by approximately 20%. It completely abolished the mitogenic effect of IGF-I and that of the combination treatment. Shear stress also significantly reduced the amounts of co-immunoprecipitated SHP-2 and -1 with IGF-IR, suggesting that the synergy between shear stress and IGF-I in osteoblast proliferation involves integrin-dependent recruitment of SHP-2 and -1 away from IGF-IR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778506     DOI: 10.1074/jbc.M501460200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Skeletal unloading-induced insulin-like growth factor 1 (IGF-1) nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling.

Authors:  Roger K Long; Shigeki Nishida; Takuo Kubota; Yongmei Wang; Takeshi Sakata; Hashem Z Elalieh; Bernard P Halloran; Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

2.  AlphaVbeta3 integrin ligands enhance volume-sensitive calcium influx in mechanically stretched osteocytes.

Authors:  Akimitsu Miyauchi; Masayuki Gotoh; Hiroshi Kamioka; Kohei Notoya; Hideki Sekiya; Yasuyuki Takagi; Yoshio Yoshimoto; Hitoshi Ishikawa; Kazuo Chihara; Teruko Takano-Yamamoto; Takuo Fujita; Yuko Mikuni-Takagaki
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 3.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  Response of a preosteoblastic cell line to cyclic tensile stress conditioning and growth factors for bone tissue engineering.

Authors:  Eunna Chung; Marissa Nichole Rylander
Journal:  Tissue Eng Part A       Date:  2011-11-08       Impact factor: 3.845

Review 5.  Evidence for pleiotropic factors in genetics of the musculoskeletal system.

Authors:  David Karasik; Douglas P Kiel
Journal:  Bone       Date:  2010-02-10       Impact factor: 4.398

6.  Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts.

Authors:  Hema Rangaswami; Raphaela Schwappacher; Nisha Marathe; Shunhui Zhuang; Darren E Casteel; Bodo Haas; Yong Chen; Alexander Pfeifer; Hisashi Kato; Sanford Shattil; Gerry R Boss; Renate B Pilz
Journal:  Sci Signal       Date:  2010-12-21       Impact factor: 8.192

7.  Role of WNT16 in the regulation of periosteal bone formation in female mice.

Authors:  Jon E Wergedal; Chandrasekhar Kesavan; Robert Brommage; Subhashri Das; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-12-18       Impact factor: 4.736

8.  Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.

Authors:  Kristopher C Carver; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

9.  Activation of integrin α5 mediated by flow requires its translocation to membrane lipid rafts in vascular endothelial cells.

Authors:  Xiaoli Sun; Yi Fu; Mingxia Gu; Lu Zhang; Dan Li; Hongliang Li; Shu Chien; John Y-J Shyy; Yi Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-05       Impact factor: 11.205

10.  The polycystic kidney disease 1 (Pkd1) gene is required for the responses of osteochondroprogenitor cells to midpalatal suture expansion in mice.

Authors:  Bo Hou; Elona Kolpakova-Hart; Naomi Fukai; Kimberly Wu; Bjorn R Olsen
Journal:  Bone       Date:  2009-03-02       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.